The Reporting of Harms in Randomized Controlled Trials of Hypertension Using the CONSORT Criteria for Harm Reporting

被引:22
|
作者
Bagul, Nitin Babulal [1 ]
Kirkham, Jamie J. [2 ]
机构
[1] Novartis Horsham Res Ctr, Horsham RH12 5AB, W Sussex, England
[2] Univ Liverpool, Dept Biostat, Liverpool L69 3GS, Merseyside, England
关键词
harm; adverse event; CONSORT; CONSORT extension; drug safety; ADVERSE EVENTS; QUALITY; STATEMENT; IMPROVE;
D O I
10.3109/10641963.2012.681724
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this study was to assess the quality of reporting of harms in hypertension clinical trials identified from the Cochrane Database using the Consolidated Standards of Reporting Trials (CONSORT) extension for harms reporting. Forty-one hypertension trials were included in the study. On average trials reported less than half of the items recommended by the CONSORT extension for harms (mean 9.83 items; 95% confidence interval 8.06, 11.60). Trialists need to address the perceived shortcomings in measurement, analysis, and reporting of harms data so that the available trial data can be considered as a balanced and reliable source of evidence.
引用
收藏
页码:548 / 554
页数:7
相关论文
共 50 条
  • [21] Quality of reporting Randomized Controlled Trials (RCTs) in nursing literature: Application of the Consolidated Standards Reporting Trials (CONSORT)
    Smith, Barbara A.
    Lee, Hyeon-Joo
    Lee, Ju Hee
    Choi, Mona
    Jones, Deborah E.
    Bousell, R. Barker
    Broome, Marion E.
    NURSING OUTLOOK, 2008, 56 (01) : 31 - 37
  • [22] Adherence of Randomized Controlled Trials in Heart Failure to Consort Reporting Standards
    Jalloh, Mohamed Bella
    Bot, Veronica A.
    Borjaille, Cristiana
    Van Spall, Harriette G.
    CIRCULATION, 2023, 148
  • [23] Reporting randomized, controlled trials of herbal interventions: An elaborated CONSORT statement
    Gagnier, JJ
    Boon, H
    Rochon, P
    Moher, D
    Barnes, J
    Bombardier, C
    ANNALS OF INTERNAL MEDICINE, 2006, 144 (05) : 364 - 367
  • [24] A "CONSORT'd'' Effort to Improve the Reporting of Urological Randomized Controlled Trials
    Sylvester, Richard J.
    EUROPEAN UROLOGY, 2016, 70 (06) : 1050 - 1051
  • [25] CONSORT revised - Improving the reporting of randomized trials
    Rennie, D
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (15): : 2006 - 2007
  • [26] Reporting of Harm in Randomized Controlled Trials Published in the Urological Literature
    Breau, Rodney H.
    Gaboury, Isabelle
    Scales, Charles D., Jr.
    Fesperman, Susan F.
    Watterson, James D.
    Dahm, Philipp
    JOURNAL OF UROLOGY, 2010, 183 (05): : 1693 - 1697
  • [27] REPORTING OF HARM IN RANDOMIZED CONTROLLED TRIALS PUBLISHED IN THE UROLOGICAL LITERATURE
    Breau, Rodney H.
    Gaboury, Isabelle
    Scales, Charles D., Jr.
    Fesperman, Susan F.
    Watterson, James D.
    Dahm, Philipp
    JOURNAL OF UROLOGY, 2009, 181 (04): : 6 - 6
  • [28] Adherence to the Consolidated Standards of Reporting Trials (CONSORT) Guidelines for Reporting Randomized Controlled Trials Related to Mandibular Third Molars
    Kshirsagar, Kapil
    Bhate, Kalyani
    Shete, Anagha
    Kakodkar, Pradnya
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2021, 79 (06) : 1207 - 1213
  • [29] Reporting of harms by randomised controlled trials in ophthalmology
    O'Day, Roderick
    Walton, Richard
    Blennerhassett, Richard
    Gillies, Mark C.
    Barthelmes, Daniel
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2014, 98 (08) : 1003 - 1008
  • [30] Reporting quality of randomized controlled trials in otolaryngology: review of adherence to the CONSORT statement
    Yu Qing Huang
    Katsiaryna Traore
    Badr Ibrahim
    Maida J. Sewitch
    Lily H. P. Nguyen
    Journal of Otolaryngology - Head & Neck Surgery, 47